Logo image of OGI

ORGANIGRAM GLOBAL INC (OGI) Stock Fundamental Analysis

NASDAQ:OGI - Nasdaq - CA68617J1003 - Common Stock - Currency: USD

1.46  0 (0%)

After market: 1.44 -0.02 (-1.37%)

Fundamental Rating

3

Taking everything into account, OGI scores 3 out of 10 in our fundamental rating. OGI was compared to 193 industry peers in the Pharmaceuticals industry. OGI may be in some trouble as it scores bad on both profitability and health. OGI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

OGI had positive earnings in the past year.
OGI had a negative operating cash flow in the past year.
OGI had negative earnings in each of the past 5 years.
OGI had negative operating cash flow in 4 of the past 5 years.
OGI Yearly Net Income VS EBIT VS OCF VS FCFOGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

OGI has a Return On Assets of 3.14%. This is amongst the best in the industry. OGI outperforms 85.49% of its industry peers.
OGI's Return On Equity of 4.32% is amongst the best of the industry. OGI outperforms 83.94% of its industry peers.
Industry RankSector Rank
ROA 3.14%
ROE 4.32%
ROIC N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
OGI Yearly ROA, ROE, ROICOGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

OGI has a better Profit Margin (8.70%) than 86.01% of its industry peers.
The Operating Margin and Gross Margin are not available for OGI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 8.7%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OGI Yearly Profit, Operating, Gross MarginsOGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

OGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
OGI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for OGI has been increased compared to 5 years ago.
Compared to 1 year ago, OGI has a worse debt to assets ratio.
OGI Yearly Shares OutstandingOGI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OGI Yearly Total Debt VS Total AssetsOGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

OGI has an Altman-Z score of -0.21. This is a bad value and indicates that OGI is not financially healthy and even has some risk of bankruptcy.
OGI's Altman-Z score of -0.21 is in line compared to the rest of the industry. OGI outperforms 50.78% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that OGI is not too dependend on debt financing.
OGI has a Debt to Equity ratio of 0.11. This is comparable to the rest of the industry: OGI outperforms 49.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -0.21
ROIC/WACCN/A
WACC8.67%
OGI Yearly LT Debt VS Equity VS FCFOGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

OGI has a Current Ratio of 3.42. This indicates that OGI is financially healthy and has no problem in meeting its short term obligations.
OGI has a Current ratio (3.42) which is in line with its industry peers.
A Quick Ratio of 1.90 indicates that OGI should not have too much problems paying its short term obligations.
OGI's Quick ratio of 1.90 is in line compared to the rest of the industry. OGI outperforms 40.93% of its industry peers.
Industry RankSector Rank
Current Ratio 3.42
Quick Ratio 1.9
OGI Yearly Current Assets VS Current LiabilitesOGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.81% over the past year.
The Revenue has grown by 26.93% in the past year. This is a very strong growth!
The Revenue has been growing by 14.73% on average over the past years. This is quite good.
EPS 1Y (TTM)101.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%226.92%
Revenue 1Y (TTM)26.93%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%74.34%

3.2 Future

OGI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.09% yearly.
Based on estimates for the next years, OGI will show a quite strong growth in Revenue. The Revenue will grow by 18.97% on average per year.
EPS Next Y49.21%
EPS Next 2Y38.52%
EPS Next 3Y29.86%
EPS Next 5Y19.09%
Revenue Next Year48.22%
Revenue Next 2Y31.13%
Revenue Next 3Y26.16%
Revenue Next 5Y18.97%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OGI Yearly Revenue VS EstimatesOGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
OGI Yearly EPS VS EstimatesOGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.20 indicates a quite expensive valuation of OGI.
OGI's Price/Earnings ratio is rather cheap when compared to the industry. OGI is cheaper than 81.35% of the companies in the same industry.
OGI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.48.
OGI is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 29.2
Fwd PE N/A
OGI Price Earnings VS Forward Price EarningsOGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OGI Per share dataOGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

OGI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OGI's earnings are expected to grow with 29.86% in the coming years.
PEG (NY)0.59
PEG (5Y)N/A
EPS Next 2Y38.52%
EPS Next 3Y29.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OGI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORGANIGRAM GLOBAL INC

NASDAQ:OGI (7/17/2025, 8:00:02 PM)

After market: 1.44 -0.02 (-1.37%)

1.46

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)08-11 2025-08-11
Inst Owners5.59%
Inst Owner Change0%
Ins Owners2.47%
Ins Owner ChangeN/A
Market Cap195.46M
Analysts77.78
Price Target2.07 (41.78%)
Short Float %6.22%
Short Ratio9.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)258.42%
Min EPS beat(2)-400%
Max EPS beat(2)916.83%
EPS beat(4)2
Avg EPS beat(4)131.47%
Min EPS beat(4)-400%
Max EPS beat(4)916.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.11%
Min Revenue beat(2)-12.23%
Max Revenue beat(2)6%
Revenue beat(4)3
Avg Revenue beat(4)0.09%
Min Revenue beat(4)-12.23%
Max Revenue beat(4)6%
Revenue beat(8)4
Avg Revenue beat(8)-1.86%
Revenue beat(12)6
Avg Revenue beat(12)-0.65%
Revenue beat(16)9
Avg Revenue beat(16)1.46%
PT rev (1m)-1.14%
PT rev (3m)4.27%
EPS NQ rev (1m)51.61%
EPS NQ rev (3m)51.61%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.23%
Revenue NQ rev (3m)4.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.13%
Valuation
Industry RankSector Rank
PE 29.2
Fwd PE N/A
P/S 1.38
P/FCF N/A
P/OCF N/A
P/B 0.69
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)0.05
EY3.42%
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.46
OCFYN/A
SpS1.06
BVpS2.13
TBVpS1.55
PEG (NY)0.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.14%
ROE 4.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 8.7%
GM N/A
FCFM N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 77.7%
Cap/Sales 5.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.42
Quick Ratio 1.9
Altman-Z -0.21
F-Score3
WACC8.67%
ROIC/WACCN/A
Cap/Depr(3y)118.74%
Cap/Depr(5y)166.77%
Cap/Sales(3y)18.54%
Cap/Sales(5y)32.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%226.92%
EPS Next Y49.21%
EPS Next 2Y38.52%
EPS Next 3Y29.86%
EPS Next 5Y19.09%
Revenue 1Y (TTM)26.93%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%74.34%
Revenue Next Year48.22%
Revenue Next 2Y31.13%
Revenue Next 3Y26.16%
Revenue Next 5Y18.97%
EBIT growth 1Y8.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year134.97%
EBIT Next 3Y49.25%
EBIT Next 5Y29.71%
FCF growth 1Y-7.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-100.66%
OCF growth 3YN/A
OCF growth 5YN/A